Menu
GeneBe

ATP6V1B1

ATPase H+ transporting V1 subunit B1, the group of V-type ATPase subunits|ATPase F1/V1 alpha/A and beta/B subunit family

Basic information

Region (hg38): 2:70935899-70965431

Previous symbols: [ "VPP3", "ATP6B1" ]

Links

ENSG00000116039NCBI:525OMIM:192132HGNC:853Uniprot:P15313AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autosomal recessive distal renal tubular acidosis (Supportive), mode of inheritance: AR
  • renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (Definitive), mode of inheritance: AR
  • renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (Strong), mode of inheritance: AR
  • renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (Definitive), mode of inheritance: AR
  • renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (Strong), mode of inheritance: AR
  • renal tubular acidosis, distal, 2, with progressive sensorineural hearing loss (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Renal tubular acidosis, distal, 2, with progressive sensorineural hearing lossARRenalIndividuals can present in infancy with acute with dehydration (which can be lethal), which can be prevented by early recognitionAudiologic/Otolaryngologic; Renal9916796; 12414817; 12566520; 16433694; 18798332

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ATP6V1B1 gene.

  • not provided (477 variants)
  • Renal tubular acidosis with progressive nerve deafness (151 variants)
  • not specified (49 variants)
  • Inborn genetic diseases (26 variants)
  • ATP6V1B1-related condition (4 variants)
  • Distal renal tubular acidosis (3 variants)
  • Hearing impairment (2 variants)
  • Renal tubular acidosis (2 variants)
  • Nephrocalcinosis;Nephrolithiasis (1 variants)
  • Nephrocalcinosis;Polydactyly, postaxial, type A1 (1 variants)
  • Usher syndrome (1 variants)
  • Abnormality of the genitourinary system (1 variants)
  • Rare genetic deafness (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATP6V1B1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
174
clinvar
6
clinvar
183
missense
4
clinvar
5
clinvar
101
clinvar
3
clinvar
1
clinvar
114
nonsense
17
clinvar
6
clinvar
1
clinvar
24
start loss
1
clinvar
1
clinvar
2
frameshift
23
clinvar
6
clinvar
29
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
6
clinvar
13
clinvar
1
clinvar
20
splice region
3
31
34
non coding
5
clinvar
63
clinvar
32
clinvar
100
Total 50 30 112 240 41

Highest pathogenic variant AF is 0.0000463

Variants in ATP6V1B1

This is a list of pathogenic ClinVar variants found in the ATP6V1B1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-70935921-C-T Renal tubular acidosis with progressive nerve deafness • not specified Benign (Jul 10, 2021)336915
2-70935936-C-T Renal tubular acidosis with progressive nerve deafness Conflicting classifications of pathogenicity (Jun 01, 2018)684162
2-70935938-C-T Renal tubular acidosis with progressive nerve deafness • ATP6V1B1-related disorder Likely benign (Jun 09, 2021)336916
2-70935955-A-C Renal tubular acidosis with progressive nerve deafness Uncertain significance (Mar 21, 2022)957463
2-70935956-T-C not specified • Renal tubular acidosis with progressive nerve deafness Benign (Feb 01, 2024)44228
2-70935958-G-T Renal tubular acidosis with progressive nerve deafness • Inborn genetic diseases Uncertain significance (Jan 10, 2023)1210757
2-70935959-C-A not specified • Renal tubular acidosis with progressive nerve deafness Uncertain significance (Feb 20, 2015)228447
2-70935960-C-G Likely benign (Jul 25, 2023)2819343
2-70935960-C-T Renal tubular acidosis with progressive nerve deafness Likely benign (Sep 30, 2023)1111351
2-70935972-C-G Uncertain significance (May 24, 2022)1801127
2-70935972-C-T Likely benign (Sep 29, 2022)1118279
2-70935978-G-GC Pathogenic (Oct 23, 2021)1360645
2-70935980-CT-C Pathogenic (Jan 11, 2024)2899094
2-70935981-T-C not specified • Renal tubular acidosis with progressive nerve deafness Benign (Feb 01, 2024)44227
2-70935981-TG-C Renal tubular acidosis with progressive nerve deafness Pathogenic/Likely pathogenic (Dec 22, 2021)966396
2-70935981-TG-T Pathogenic (Sep 29, 2021)936069
2-70935981-T-TG Renal tubular acidosis with progressive nerve deafness Pathogenic (Jan 09, 2024)1458122
2-70935984-G-A Likely benign (Mar 01, 2023)2651016
2-70935987-G-A Likely benign (Oct 04, 2023)1654381
2-70935987-G-C Renal tubular acidosis with progressive nerve deafness Conflicting classifications of pathogenicity (Jan 05, 2024)336917
2-70935990-C-A Likely benign (Jun 09, 2023)1086864
2-70935990-C-T Likely benign (Aug 25, 2023)2828893
2-70935993-C-T Likely benign (Jan 31, 2024)1118801
2-70935994-G-A not specified • Renal tubular acidosis with progressive nerve deafness Benign/Likely benign (Jan 29, 2024)761407
2-70935994-G-C Inborn genetic diseases Uncertain significance (Aug 01, 2022)2304137

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ATP6V1B1protein_codingprotein_codingENST00000234396 1429525
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.40e-90.8901257000481257480.000191
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2322973080.9630.00001993344
Missense in Polyphen108124.020.870851300
Synonymous0.3731211260.9580.000008751025
Loss of Function1.771828.20.6390.00000170291

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004230.000423
Ashkenazi Jewish0.00009940.0000992
East Asian0.0002720.000272
Finnish0.000.00
European (Non-Finnish)0.0001940.000193
Middle Eastern0.0002720.000272
South Asian0.0002940.000294
Other0.0003270.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Non-catalytic subunit of the peripheral V1 complex of vacuolar ATPase. V-ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells.;
Disease
DISEASE: Renal tubular acidosis, distal, with progressive nerve deafness (dRTA-D) [MIM:267300]: An autosomal recessive disease characterized by the association of renal distal tubular acidosis with sensorineural hearing loss. Distal renal tubular acidosis is characterized by reduced ability to acidify urine, variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis. It is due to functional failure of alpha- intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification. {ECO:0000269|PubMed:12414817, ECO:0000269|PubMed:12579397, ECO:0000269|PubMed:9916796}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
mTOR signaling pathway - Homo sapiens (human);Synaptic vesicle cycle - Homo sapiens (human);Phagosome - Homo sapiens (human);Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Collecting duct acid secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);Rheumatoid arthritis - Homo sapiens (human);Signal Transduction;Transferrin endocytosis and recycling;Ion channel transport;Insulin receptor recycling;Signaling by Insulin receptor;ROS, RNS production in phagocytes;Purine metabolism;Innate Immune System;Immune System;Transport of small molecules;Iron uptake and transport;Signaling by Receptor Tyrosine Kinases (Consensus)

Recessive Scores

pRec
0.324

Intolerance Scores

loftool
0.264
rvis_EVS
-0.48
rvis_percentile_EVS
22.75

Haploinsufficiency Scores

pHI
0.166
hipred
Y
hipred_score
0.578
ghis
0.471

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.692

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyHighMediumHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Atp6v1b1
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; skeleton phenotype; renal/urinary system phenotype; homeostasis/metabolism phenotype; taste/olfaction phenotype;

Gene ontology

Biological process
ossification;regulation of pH;excretion;sensory perception of sound;insulin receptor signaling pathway;ATP hydrolysis coupled proton transport;regulation of macroautophagy;transferrin transport;ion transmembrane transport;inner ear morphogenesis;pH reduction;ATP metabolic process;calcium ion homeostasis;proton transmembrane transport
Cellular component
cytoplasm;cytosol;microvillus;basolateral plasma membrane;apical plasma membrane;lateral plasma membrane;vacuolar proton-transporting V-type ATPase complex;proton-transporting V-type ATPase, V1 domain;extracellular exosome;extrinsic component of synaptic vesicle membrane
Molecular function
ATP binding;proton transmembrane transporter activity;hydrolase activity;protein-containing complex binding